Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-18 Sale | 2023-01-20 4:34 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 8,037 | $26.89 | $216,115 | 417,599 (Direct) | View |
| 2022-10-18 Sale | 2022-10-20 4:53 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 11,156 | $25.2 | $281,131 | 425,636 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:36 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 11,164 | $12.87 | $143,681 | 436,792 (Direct) | View |
| 2022-04-19 Sale | 2022-04-21 4:25 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 24,594 | $10.45 | $257,007 | 447,956 (Direct) | View |
| 2022-01-19 Sale | 2022-01-21 4:08 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 19,882 | $14.68 | $291,868 | 337,983 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-10 Disposition | 2023-03-10 09:30 am | N/A 2031-01-14 | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 1,271,619 | $0 | 0 (Direct) | View |
| 2022-04-15 Option Award | 2022-04-19 4:46 pm | N/A 2032-04-14 | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 339,375 | $0 | 677,358 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:13 pm | N/A 2031-04-14 | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 343,007 | $0 | 566,083 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:41 pm | N/A 2031-01-14 | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 529,503 | $0 | 529,503 (Direct) | View |
Ownership | 2021-01-12 6:50 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 0 | $0 | 0 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 9:19 pm | N/A 2030-03-16 | Axsome Therapeutics Inc. | AXSM | Marek David C Chief Commercial Officer | 70,517 | $0 | 70,517 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:42 pm | N/A 2029-10-09 | Axsome Therapeutics Inc. | AXSM | Marek David C Chief Commercial Officer | 25,813 | $0 | 25,813 (Direct) | View |
| 2019-09-04 Option Award | 2019-09-06 7:01 pm | N/A 2029-09-04 | Axsome Therapeutics Inc. | AXSM | Marek David C Chief Commercial Officer | 125,000 | $0 | 125,000 (Direct) | View |